Journal
MICROBIAL DRUG RESISTANCE
Volume 20, Issue 4, Pages 259-263Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/mdr.2013.0127
Keywords
-
Funding
- Spanish Network for the research in infectious diseases [REIPI RD12/0015]
- Fondo de Investigaciones Sanitarias [PI12/00552]
- European Community, FP 7 [278232]
- Union Europea-Fondo Europeo de Desarrollo Regional (FEDER)
- Instituto de Salud Carlos III-Ministerio Economia y Competitividad Union Europea-Fondo Europeo de Desarrollo Regional (FEDER) [PI11/01034]
Ask authors/readers for more resources
Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 50 patients between July 2011 and July 2012 at the University Hospital A Coruna (NW Spain). These multidrug-resistant isolates, which belonged to a single clone, remained only susceptible to tigecycline, minocycline, and colistin and produced the carbapenem-hydrolyzing oxacillinase, OXA-23. This is the first reported outbreak of OXA-23-producing A. baumannii isolates in Spain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
